Home > Healthcare > Drug Device Combination > Drug Filled Devices > Prefilled Syringes Market

Prefilled Syringes Market Size

Report ID: GMI1968
Published Date: Feb 2021
Report Format: PDF

Download Free Sample

Prefilled Syringes Market Size

Prefilled Syringes Market size surpassed USD 5.8 billion in 2020 and is expected to witness over 11.8% CAGR from 2021 to 2027.

To get key market trends
Download Free Sample

Growing demand for advanced drug delivery devices for accurate dosing and improved safety will propel the market growth. Increasing prevalence of diabetes and rheumatoid arthritis, and escalating adoption of biosimilars in developed regions are some other factors that will fuel the market expansion. Additionally, the COVID-19 pandemic and similar other historical public health emergencies have shown importance of advanced drug delivery systems during tough times.

Prefilled Syringes Market Report Attributes
Report Attribute	Details
Base Year:	2020
Prefilled Syringes Market Size in 2020:	USD 5.9 Billion
Forecast Period:	2021 to 2027
Forecast Period 2021 to 2027 CAGR:	11.8%
2027 Value Projection:	USD 12.8 Billion
Historical Data for:	2016 to 2020
No. of Pages:	116
Tables, Charts & Figures:	113
Segments covered:	Type, Design, Applications and Region
Growth Drivers:	Growing concerns regarding safety of injectables Worldwide increase in incidences of diabetes and rheumatoid arthritis Technological advancements in prefilled syringes in North America Growing adoption of biosimilars in developed regions
Pitfalls & Challenges:	Complexities associated with prefilled syringes

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global prefilled syringes industry size was over USD 5.8 billion in 2020 will reach a valuation of over USD 12.7 billion by 2027.

The glass-based prefilled syringes market size had surpassed USD 4.1 billion during 2020 due to their wide use for the delivery of highly viscous medications across distinct therapeutic areas.

The industry share from single-chamber design segment had reached USD 4.6 billion in 2020 with benefits like precise dosage and improved safety.

The diabetes segment held over 34% of the global market share in 2020 and will grow owing to the constant use of medications during treatment of the disorder.

North America prefilled syringes industry share will register around 12% CAGR between 2021-2027 with consistent rise in geriatric population prone to chronic disorders across the U.S.